open access

Vol 72, No 4 (2021)
Letter to the Editor
Submitted: 2021-12-11
Accepted: 2021-12-13
Published online: 2021-12-30
Get Citation

Deep-sea antibiotics exploitation: PROs and CONs

Iyiola Olatunji Oladunjoye1, Joy Ginika Ikebuaso2, Christian Tochukwu Agboeze3, Yusuf Amuda Tajudeen1
·
Pubmed: 35146733
·
IMH 2021;72(4):312.
Affiliations
  1. Department of Microbiology, Faculty of Life Sciences, University of Ilorin, Ilorin, Nigeria
  2. Department of Microbiology, Faculty of Natural Sciences, Chukwuemeka Odumegwu Ojukwu University, Ihiala, Nigeria
  3. Department of Microbiology, Faculty of Biological Sciences, University of Nigeria, Nsukka, Nigeria

open access

Vol 72, No 4 (2021)
LETTERS TO THE EDITOR
Submitted: 2021-12-11
Accepted: 2021-12-13
Published online: 2021-12-30

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Deep-sea antibiotics exploitation: PROs and CONs

Journal

International Maritime Health

Issue

Vol 72, No 4 (2021)

Article type

Letter to the Editor

Pages

312

Published online

2021-12-30

Page views

6007

Article views/downloads

341

DOI

10.5603/IMH.2021.0059

Pubmed

35146733

Bibliographic record

IMH 2021;72(4):312.

Authors

Iyiola Olatunji Oladunjoye
Joy Ginika Ikebuaso
Christian Tochukwu Agboeze
Yusuf Amuda Tajudeen

References (4)
  1. Hug JJ, Bader CD, Remškar M, et al. Concepts and methods to access novel antibiotics from actinomycetes. Antibiotics (Basel). 2018; 7(2).
  2. Sivalingam P, Hong K, Pote J, et al. Extreme environment : potential sources for new antibacterial and anticancer drug leads? Int J Microbiol. 2019; 2019: 5283948.
  3. Arico S, Salpin C. Bioprospecting of genetic resources in the deep seabed; Scientific, legal, and policy aspects. Industrial Biotechnology. 2005; 1(4): 260–282.
  4. Rademaekers K, Widerberg O, Svatikova K, van der Veen R, Panella E. Technology options for deep-seabed exploitation Tackling economic, environmental and societal challenges. STOA project carried out by Triple E Consulting and Milieu Ltd. at the request of the Science and Technology Options Assessment (STOA) Panel, within the Directorate-General for Parliamentary Research Services (DG EPRS) of the General Secretariat of the European Parliament. 2015 Mar.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl